Impact of Xenazine (Tetrabenazine) on Gait and Functional Activity in Individuals With Huntington's Disease.
Phase of Trial: Phase IV
Latest Information Update: 26 Nov 2017
At a glance
- Drugs Tetrabenazine (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2011 New trial record